Chemung Canal Trust’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-5,000
Closed -$707K – 120
2023
Q1
$707K Hold
5,000
– – 0.16% 80
2022
Q4
$782K Hold
5,000
– – 0.18% 81
2022
Q3
$613K Hold
5,000
– – 0.15% 86
2022
Q2
$665K Hold
5,000
– – 0.15% 85
2022
Q1
$684K Hold
5,000
– – 0.13% 86
2021
Q4
$865K Hold
5,000
– – 0.16% 82
2021
Q3
$727K Hold
5,000
– – 0.14% 85
2021
Q2
$660K Hold
5,000
– – 0.13% 90
2021
Q1
$642K Hold
5,000
– – 0.13% 90
2020
Q4
$596K Hold
5,000
– – 0.13% 87
2020
Q3
$572K Hold
5,000
– – 0.14% 90
2020
Q2
$570K Hold
5,000
– – 0.15% 89
2020
Q1
$402K Hold
5,000
– – 0.12% 86
2019
Q4
$534K Hold
5,000
– – 0.12% 95
2019
Q3
$535K Hold
5,000
– – 0.13% 88
2019
Q2
$509K Hold
5,000
– – 0.12% 89
2019
Q1
$450K Buy
+5,000
New +$433K 0.11% 89
2015
Q3
– Sell
-3,034
Closed -$221K – 132
2015
Q2
$221K Hold
3,034
– – 0.05% 128
2015
Q1
$233K Sell
3,034
-172
-5% -$12.3K 0.05% 129
2014
Q4
$215K Buy
+3,206
New +$202K 0.04% 132

Other funds holding DGX

Chemung Canal Trust's DGX Position: Q2 2023 in Review

Chemung Canal Trust sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 5,000 shares — an estimated $707K sold.

Chemung Canal Trust first reported a position in DGX in Q4 2014 and held it in 20 quarters. The position peaked at $865K in Q4 2021. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • Chemung Canal Trust reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
  • Chemung Canal Trust sold 5,000 Quest Diagnostics shares in Q2 2023, an estimated $707K.
  • Chemung Canal Trust first reported a position in Quest Diagnostics in Q4 2014 and held it in 20 quarters.
  • Chemung Canal Trust's Quest Diagnostics position peaked at $865K in Q4 2021.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on Chemung Canal Trust's 13F filing for Q2 2023, filed 21 Jul 2023.